Lobbying

Pharmadva's latest lobbying report covers Q2 2026, at $8,000. The four quarters Q4 2025–Q3 2026 total $24K. Its first report covers Q2 2025; the issues it reports most are Veterans.

Pharmadva

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$24K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q2 2025
The first quarter a report named it

Lobbying by quarter

Pharmadva lobbying by quarter
Pharmadva lobbying by quarter
QuarterAmountReports
Q2 2025$01
Q3 2025$10K1
Q4 2025$8,0001
Q1 2026$8,0001
Q2 2026$8,0001
Q3 2026$00

By issue

  • Veterans$34K · 5 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES5 reports
  • SENATE3 reports
  • Veterans Affairs, Dept of (VA)3 reports

Firms it paid

Firm
Carol G Holladay & Associates$34K5 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/20for Q1Carol G Holladay & Associates$8,000
07/20for Q2Carol G Holladay & Associates$8,000
04/20for Q1Carol G Holladay & Associates$8,000
01/20for Q4 2025Carol G Holladay & Associates$8,000
25/10/20for Q3 2025Carol G Holladay & Associates$10K
25/07/21for Q2 2025Carol G Holladay & AssociatesUnder $5,000
25/06/24for Q2 2025Carol G Holladay & AssociatesUnder $5,000